United States securities and exchange commission logo





                              November 16, 2022

       Bradley A. Bostic
       Chief Executive Officer
       Future Health ESG Corp.
       8 The Green, Suite 12081
       Dover, DE 19901

                                                        Re: Future Health ESG
Corp.
                                                            Preliminary Proxy
on Schedule 14A
                                                            Filed November 9,
2022
                                                            File No. 001-40788

       Dear Bradley A. Bostic:

              We have limited our review of your preliminary proxy statement to
those issues we have
       addressed in our comment. In our comment, we may ask you to provide us
with information so
       we may better understand your disclosure.

              Please respond to this comment within ten business days by
providing the requested
       information or advise us as soon as possible when you will respond. If
you do not believe this
       comment applies to your facts and circumstances, please tell us why in
your response.

                                                        After reviewing your
response to this comment, we may have additional comments.

       Preliminary Proxy on Schedule 14A, Filed November 9, 2022

       General

   1.                                                   With a view toward
disclosure, please tell us whether your sponsor is, is controlled by, has
                                                        any members who are, or
has substantial ties with, a non-U.S. person. If so, please revise
                                                        your filing to include
risk factor disclosure that addresses how this fact could impact your
                                                        ability to complete
your initial business combination. For instance, discuss the risk to
                                                        investors that you may
not be able to complete an initial business combination with a
                                                        target company should
the transaction be subject to review by a U.S. government entity,
                                                        such as the Committee
on Foreign Investment in the United States (CFIUS), or ultimately
                                                        prohibited. Disclose
that as a result, the pool of potential targets with which you could
                                                        complete an initial
business combination may be limited. Further, disclose that the time
                                                        necessary for
government review of the transaction or a decision to prohibit the
                                                        transaction could
prevent you from completing an initial business combination and require
                                                        you to liquidate.
Disclose the consequences of liquidation to investors, such as the losses
 Bradley A. Bostic
Future Health ESG Corp.
November 16, 2022
Page 2
      of the investment opportunity in a target company, any price appreciation
in the combined
      company, and the warrants, which would expire worthless.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.

       Please contact Margaret Schwartz at 202-551-7153 or Dorrie Yale at
202-551-8776 with
any questions.



                                                          Sincerely,

FirstName LastNameBradley A. Bostic                       Division of
Corporation Finance
                                                          Office of Industrial
Applications and
Comapany NameFuture Health ESG Corp.
                                                          Services
November 16, 2022 Page 2
cc:       Ari Edelman, Esq.
FirstName LastName